How to overcome resistance of influenza A viruses against adamantane derivatives (Q41042632)

26 September 2017

How to overcome resistance of influenza A viruses against adamantane derivatives (English)

1 reference

26 September 2017

3

Klenk HD

1 reference

PubMed ID

9588841

26 September 2017

Christoph Scholtissek

series ordinal

1

object named as

Scholtissek C

1 reference

26 September 2017

4

Webster RG

1 reference

26 September 2017

Quack G

2

1 reference

26 September 2017

1 February 1998

1 reference

26 September 2017

1 reference

26 September 2017

37

1 reference

26 September 2017

2

1 reference

26 September 2017

83-95

1 reference

Amantadine-resistance as a Genetic Marker for Influenza Viruses

26 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900061-2

7 January 2021

Plaque Formation by Influenza Viruses in the Presence of Trypsin

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900061-2

7 January 2021

A plaque assay for the study of influenza virus inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900061-2

7 January 2021

Electrophoretic analysis of iodine-labeled influenza virus RNA segments

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900061-2

7 January 2021

Biologic potential of amantadine-resistant influenza A virus in an avian model

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900061-2

7 January 2021

Studies on the antiviral activity of amantadine hydrochloride.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900061-2

7 January 2021

Fusion mutants of the influenza virus hemagglutinin glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900061-2

7 January 2021

Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents--preclinical studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900061-2

7 January 2021

ANTIVIRAL ACTIVITY OF 1-ADAMANTANAMINE (AMANTADINE).

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900061-2

7 January 2021

The transmembrane domain of influenza A M2 protein forms amantadine-sensitive proton channels in planar lipid bilayers

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900061-2

7 January 2021

The molecular basis of the specific anti-influenza action of amantadine

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900061-2

7 January 2021

Influenza viruses cause hemolysis and fusion of cells

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900061-2

7 January 2021

Inhibition of uncoating of fowl plague virus by l-adamantanamine hydrochloride

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900061-2

7 January 2021

Synthesis and antiviral activity evaluation of some aminoadamantane derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900061-2

7 January 2021

Synthesis and antiviral activity evaluation of some new aminoadamantane derivatives. 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900061-2

7 January 2021

Different modes of inhibition by adamantane amine derivatives and natural polyamines of the functionally reconstituted influenza virus M2 proton channel protein

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900061-2

7 January 2021

Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900061-2

7 January 2021

Influenza virus M2 protein has ion channel activity

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900061-2

7 January 2021

DNA sequencing with chain-terminating inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900061-2

7 January 2021

Origin of the pandemic 1957 H2 influenza A virus and the persistence of its possible progenitors in the avian reservoir

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900061-2

7 January 2021

Amantadine and dansylcadaverine inhibit vesicular stomatitis virus uptake and receptor-mediated endocytosis of alpha 2-macroglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900061-2

7 January 2021

Functional reconstitution in lipid vesicles of influenza virus M2 protein expressed by baculovirus: evidence for proton transfer activity

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900061-2

7 January 2021

Influenza virus M2 protein: a molecular modelling study of the ion channel.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900061-2

7 January 2021

Amantadine selection of a mutant influenza virus containing an acid-stable hemagglutinin glycoprotein: evidence for virus-specific regulation of the pH of glycoprotein transport vesicles

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900061-2

7 January 2021

Structural characteristics of the M2 protein of influenza A viruses: evidence that it forms a tetrameric channel

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900061-2

7 January 2021

Rational design of potent sialidase-based inhibitors of influenza virus replication

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900061-2

7 January 2021

Nucleotide sequences of influenza A virus RNA segment 7: a comparison of five isolates.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900061-2

7 January 2021

10.1016/S0166-3542(97)00061-2

Identifiers

DOI

1 reference

26 September 2017

1 reference

PubMed ID

9588841